Brandes Investment Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.4M | Sell |
279,660
-139,502
| -33% | -$32.5M | 0.48% | 74 |
|
|
2025
Q4 | $86.7M | Sell |
419,162
-1,888
| -0.4% | -$373K | 0.66% | 56 |
|
|
2025
Q3 | $78.1M | Buy |
421,050
+10,285
| +3% | +$1.76M | 0.63% | 59 |
|
|
2025
Q2 | $62.7M | Buy |
410,765
+8,502
| +2% | +$1.31M | 0.57% | 58 |
|
|
2025
Q1 | $66.7M | Buy |
402,263
+5,331
| +1% | +$834K | 0.68% | 53 |
|
|
2024
Q4 | $57.4M | Buy |
396,932
+55,609
| +16% | +$8.62M | 0.64% | 56 |
|
|
2024
Q3 | $55.3M | Buy |
341,323
+16,757
| +5% | +$2.67M | 0.62% | 55 |
|
|
2024
Q2 | $47.4M | Buy |
324,566
+47,292
| +17% | +$7.03M | 0.58% | 60 |
|
|
2024
Q1 | $43.9M | Buy |
277,274
+8,755
| +3% | +$1.39M | 0.56% | 59 |
|
|
2023
Q4 | $42.1M | Buy |
268,519
+54,639
| +26% | +$8.38M | 0.64% | 54 |
|
|
2023
Q3 | $33.3M | Buy |
213,880
+42,337
| +25% | +$6.99M | 0.65% | 50 |
|
|
2023
Q2 | $28.4M | Buy |
171,543
+8,391
| +5% | +$1.35M | 0.57% | 53 |
|
|
2023
Q1 | $25.3M | Buy |
163,152
+33,162
| +26% | +$5.35M | 0.54% | 57 |
|
|
2022
Q4 | $23M | Sell |
129,990
-22,663
| -15% | -$3.91M | 0.64% | 51 |
|
|
2022
Q3 | $24.9M | Buy |
152,653
+6,817
| +5% | +$1.15M | 0.65% | 43 |
|
|
2022
Q2 | $25.9M | Buy |
145,836
+12,101
| +9% | +$2.16M | 0.63% | 48 |
|
|
2022
Q1 | $23.7M | Buy |
133,735
+14,948
| +13% | +$2.54M | 0.51% | 49 |
|
|
2021
Q4 | $20.3M | Buy |
118,787
+1,327
| +1% | +$217K | 0.44% | 63 |
|
|
2021
Q3 | $19M | Buy |
117,460
+11,180
| +11% | +$1.91M | 0.41% | 67 |
|
|
2021
Q2 | $17.5M | Buy |
106,280
+38,444
| +57% | +$6.36M | 0.39% | 67 |
|
|
2021
Q1 | $11.2M | Buy |
67,836
+6,729
| +11% | +$1.09M | 0.26% | 78 |
|
|
2020
Q4 | $9.54M | Buy |
61,107
+6,591
| +12% | +$973K | 0.25% | 81 |
|
|
2020
Q3 | $8.12M | Sell |
54,516
-12,340
| -18% | -$1.83M | 0.28% | 78 |
|
|
2020
Q2 | $9.4M | Sell |
66,856
-9,871
| -13% | -$1.44M | 0.29% | 76 |
|
|
2020
Q1 | $10.1M | Buy |
76,727
+24,732
| +48% | +$3.51M | 0.35% | 70 |
|
|
2019
Q4 | $7.58M | Sell |
51,995
-928
| -2% | -$126K | 0.18% | 80 |
|
|
2019
Q3 | $6.85M | Sell |
52,923
-2,244
| -4% | -$296K | 0.18% | 81 |
|
|
2019
Q2 | $7.68M | Sell |
55,167
-2,405
| -4% | -$333K | 0.17% | 80 |
|
|
2019
Q1 | $8.05M | Buy |
57,572
+3,052
| +6% | +$409K | 0.19% | 78 |
|
|
2018
Q4 | $7.04M | Buy |
54,520
+1,691
| +3% | +$236K | 0.18% | 82 |
|
|
2018
Q3 | $7.3M | Sell |
52,829
-1,818
| -3% | -$242K | 0.16% | 82 |
|
|
2018
Q2 | $6.63M | Buy |
54,647
+2,941
| +6% | +$367K | 0.15% | 85 |
|
|
2018
Q1 | $6.63M | Sell |
51,706
-3,340
| -6% | -$451K | 0.14% | 83 |
|
|
2017
Q4 | $7.69M | Sell |
55,046
-3,464
| -6% | -$483K | 0.16% | 83 |
|
|
2017
Q3 | $7.61M | Sell |
58,510
-63,732
| -52% | -$8.45M | 0.15% | 83 |
|
|
2017
Q2 | $16.2M | Sell |
122,242
-10,145
| -8% | -$1.29M | 0.26% | 71 |
|
|
2017
Q1 | $16.5M | Buy |
132,387
+1,035
| +0.8% | +$124K | 0.24% | 68 |
|
|
2016
Q4 | $15.1M | Buy |
131,352
+4,725
| +4% | +$546K | 0.23% | 71 |
|
|
2016
Q3 | $15M | Sell |
126,627
-6,501
| -5% | -$789K | 0.22% | 71 |
|
|
2016
Q2 | $16.1M | Sell |
133,128
-13,125
| -9% | -$1.49M | 0.25% | 69 |
|
|
2016
Q1 | $15.8M | Sell |
146,253
-4,841
| -3% | -$501K | 0.23% | 72 |
|
|
2015
Q4 | $15.5M | Buy |
151,094
+32,585
| +27% | +$3.28M | 0.23% | 71 |
|
|
2015
Q3 | $11.1M | Buy |
+118,509
| New | +$11.5M | 0.16% | 79 |
|
Other funds holding JNJ
VCM
VPM
Brandes Investment Partners's JNJ Position: Q1 2026 in Review
Brandes Investment Partners reduced its Johnson & Johnson (JNJ) stake by 33% in Q1 2026, selling an estimated $32.5M and leaving 279,660 shares worth $68.4M. The position accounts for 0.48% of the portfolio, ranked #74.
Brandes Investment Partners first reported a position in JNJ in Q3 2015 and has held it in 43 quarters since. The position peaked at $86.7M in Q4 2025. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Brandes Investment Partners held 279,660 shares of Johnson & Johnson worth $68.4M as of Q1 2026.
- Brandes Investment Partners sold 139,502 Johnson & Johnson shares in Q1 2026, an estimated $32.5M.
- Johnson & Johnson made up 0.48% of Brandes Investment Partners's portfolio in Q1 2026, its #74 holding.
- Brandes Investment Partners first reported a position in Johnson & Johnson in Q3 2015 and has held it in 43 quarters since.
- Brandes Investment Partners's Johnson & Johnson position peaked at $86.7M in Q4 2025.
- 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.